Review
doi: 10.1002/pauz.201000358.
[DPP-4 inhibitors in clinical use. Therapy without the risk of hypoglycaemia]
[Article in
German]
Affiliations
- PMID: 20196038
- DOI: 10.1002/pauz.201000358
Item in Clipboard
Review
[DPP-4 inhibitors in clinical use. Therapy without the risk of hypoglycaemia]
[Article in
German]
Pharm Unserer Zeit.
2010 Mar.
No abstract available
Similar articles
-
[The value of incretin based therapies].Dtsch Med Wochenschr. 2009 May;134(20):1062-6. doi: 10.1055/s-0029-1222570. Epub 2009 May 6. Dtsch Med Wochenschr. 2009. PMID: 19421931 Review. German. No abstract available.
-
[Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].Dtsch Med Wochenschr. 2008 Oct;133(43):2233-7. doi: 10.1055/s-0028-1091266. Epub 2008 Oct 15. Dtsch Med Wochenschr. 2008. PMID: 18924057 Review. German. No abstract available.
-
[Therapeutic use and adverse events of incretin-related drugs].Nihon Rinsho. 2012 May;70 Suppl 3:699-702. Nihon Rinsho. 2012. PMID: 22768601 Japanese. No abstract available.
-
Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.Int J Clin Pract Suppl. 2007 Aug;(154):38-48. doi: 10.1111/j.1742-1241.2007.01439.x. Int J Clin Pract Suppl. 2007. PMID: 17593276 Review.
-
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):479-86. doi: 10.1016/j.beem.2009.03.004. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19748065
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
